Nature's Sunshine Products (NASDAQ:NATR) Announces Earnings Results

Key Points

• Nature's Sunshine Products reported a quarterly earnings per share (EPS) of $0.35, significantly exceeding analysts' expectations of $0.16.
• The company updated its FY 2025 guidance and achieved revenue of $114.75 million, surpassing expectations of $113.10 million.
• Major shareholder Fosun Pharmaceutical Shanghai sold over 2.8 million shares in June, while Jane Street Group acquired 13,831 shares, indicating ongoing institutional interest in the stock.

Nature's Sunshine Products (NASDAQ:NATR - Get Free Report) released its quarterly earnings results on Thursday. The company reported $0.35 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.16 by $0.19, Zacks reports. Nature's Sunshine Products had a net margin of 3.06% and a return on equity of 10.19%. The company had revenue of $114.75 million during the quarter, compared to analysts' expectations of $113.10 million. Nature's Sunshine Products updated its FY 2025 guidance to EPS.

Nature's Sunshine Products Stock Performance

Shares of NATR traded up $1.79 during trading hours on Friday, reaching $15.80. 150,853 shares of the company traded hands, compared to its average volume of 67,314. The stock's fifty day moving average is $14.89 and its 200 day moving average is $13.95. The stock has a market cap of $291.67 million, a P/E ratio of 21.35 and a beta of 1.14. Nature's Sunshine Products has a 1-year low of $10.81 and a 1-year high of $18.06.

Insider Activity at Nature's Sunshine Products

In other news, major shareholder Fosun Pharmaceutical Shanghai sold 2,854,607 shares of the company's stock in a transaction dated Friday, June 27th. The shares were sold at an average price of $11.46, for a total transaction of $32,713,796.22. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 4.70% of the company's stock.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Nature's Sunshine Products stock. Jane Street Group LLC acquired a new stake in shares of Nature's Sunshine Products, Inc. (NASDAQ:NATR - Free Report) in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 13,831 shares of the company's stock, valued at approximately $174,000. Jane Street Group LLC owned about 0.08% of Nature's Sunshine Products as of its most recent filing with the Securities & Exchange Commission. 79.40% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on NATR. Canaccord Genuity Group upped their price target on shares of Nature's Sunshine Products from $21.00 to $22.00 and gave the company a "buy" rating in a report on Friday. DA Davidson restated a "buy" rating and set a $19.00 price target on shares of Nature's Sunshine Products in a report on Tuesday, June 3rd.

Nature's Sunshine Products Company Profile

Nature's Sunshine Products, Inc, a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.